Blog

The below Parliamentary question was asked by Royston Smith on 2016-03-23.

To ask the Secretary of State for Health, what recent discussions he has had with the Pharmaceutical Services Negotiating Committee.

Alistair Burt

Community pharmacy is a vital part of the National Health Service and can play an even greater role. In the Spending Review, the Government re-affirmed the need for the NHS to deliver £22 billion in efficiency savings by 2020/21 as set out in the NHS’s own plan, the Five Year Forward View. Community pharmacy is a core part of NHS primary care and has an important contribution to make as the NHS rises to these challenges. The Government believes efficiencies can be made without compromising the quality of services or public access to them. Our aim is to ensure that those community pharmacies upon which people depend continue to thrive and so we are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared to others, considering factors such as location and the health needs of the local population.

The Government’s vision is for a more efficient, modern system that will free up pharmacists to spend more time delivering clinical and public health services to the benefit of patients and the public.

We have been in detailed discussions with the Pharmaceutical Services Negotiating Committee (PSNC) since December 2015 regarding the Government’s proposals for community pharmacy in 2016/17 and beyond, including the proposal for a Pharmacy Access Scheme. In parallel, we also want to hear views on our proposals from across the sector and from patient groups. We published our open letter to the PSNC on 17 December 2015 and on 27 January 2016 we published a set of slides setting out the proposals with a foreword by the Chief Pharmaceutical Officer.

We announced on 16 March 2016 that the consultation period was to be extended to allow more time to develop the proposed changes with the PSNC and others. It will now close on 24 May 2016.

Once we have carefully considered the outcomes from the consultation, we are looking to communicate final decisions as soon as possible, so that pharmacy contractors are fully informed some months before the funding reduction starts from October 2016.

The role of the general practice pharmacist is distinct from the role of the pharmacist in a community setting. However, they are synergistic. Pharmacists working in general practice will, in the main, work with patients who have long term conditions to support them with their medicines and self-management of their condition by helping with the development and review of individual care plans. These patients will not generally be those with minor illnesses which can be treated by seeing a pharmacist in a community setting and for whom community pharmacy will remain the first, and most appropriate, option.

The below Parliamentary question was asked by Royston Smith on 2016-03-23.

To ask the Secretary of State for Health, what steps he plans to take to provide information to pharmacies on proposed changes to the community pharmacy sector.

Alistair Burt

Community pharmacy is a vital part of the National Health Service and can play an even greater role. In the Spending Review, the Government re-affirmed the need for the NHS to deliver £22 billion in efficiency savings by 2020/21 as set out in the NHS’s own plan, the Five Year Forward View. Community pharmacy is a core part of NHS primary care and has an important contribution to make as the NHS rises to these challenges. The Government believes efficiencies can be made without compromising the quality of services or public access to them. Our aim is to ensure that those community pharmacies upon which people depend continue to thrive and so we are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared to others, considering factors such as location and the health needs of the local population.

The Government’s vision is for a more efficient, modern system that will free up pharmacists to spend more time delivering clinical and public health services to the benefit of patients and the public.

We have been in detailed discussions with the Pharmaceutical Services Negotiating Committee (PSNC) since December 2015 regarding the Government’s proposals for community pharmacy in 2016/17 and beyond, including the proposal for a Pharmacy Access Scheme. In parallel, we also want to hear views on our proposals from across the sector and from patient groups. We published our open letter to the PSNC on 17 December 2015 and on 27 January 2016 we published a set of slides setting out the proposals with a foreword by the Chief Pharmaceutical Officer.

We announced on 16 March 2016 that the consultation period was to be extended to allow more time to develop the proposed changes with the PSNC and others. It will now close on 24 May 2016.

Once we have carefully considered the outcomes from the consultation, we are looking to communicate final decisions as soon as possible, so that pharmacy contractors are fully informed some months before the funding reduction starts from October 2016.

The role of the general practice pharmacist is distinct from the role of the pharmacist in a community setting. However, they are synergistic. Pharmacists working in general practice will, in the main, work with patients who have long term conditions to support them with their medicines and self-management of their condition by helping with the development and review of individual care plans. These patients will not generally be those with minor illnesses which can be treated by seeing a pharmacist in a community setting and for whom community pharmacy will remain the first, and most appropriate, option.

The below Parliamentary question was asked by Royston Smith on 2016-03-23.

To ask the Secretary of State for Health, what discussions he has had with community pharmacies on the proposals for a pharmacy access scheme.

Alistair Burt

Community pharmacy is a vital part of the National Health Service and can play an even greater role. In the Spending Review, the Government re-affirmed the need for the NHS to deliver £22 billion in efficiency savings by 2020/21 as set out in the NHS’s own plan, the Five Year Forward View. Community pharmacy is a core part of NHS primary care and has an important contribution to make as the NHS rises to these challenges. The Government believes efficiencies can be made without compromising the quality of services or public access to them. Our aim is to ensure that those community pharmacies upon which people depend continue to thrive and so we are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared to others, considering factors such as location and the health needs of the local population.

The Government’s vision is for a more efficient, modern system that will free up pharmacists to spend more time delivering clinical and public health services to the benefit of patients and the public.

We have been in detailed discussions with the Pharmaceutical Services Negotiating Committee (PSNC) since December 2015 regarding the Government’s proposals for community pharmacy in 2016/17 and beyond, including the proposal for a Pharmacy Access Scheme. In parallel, we also want to hear views on our proposals from across the sector and from patient groups. We published our open letter to the PSNC on 17 December 2015 and on 27 January 2016 we published a set of slides setting out the proposals with a foreword by the Chief Pharmaceutical Officer.

We announced on 16 March 2016 that the consultation period was to be extended to allow more time to develop the proposed changes with the PSNC and others. It will now close on 24 May 2016.

Once we have carefully considered the outcomes from the consultation, we are looking to communicate final decisions as soon as possible, so that pharmacy contractors are fully informed some months before the funding reduction starts from October 2016.

The role of the general practice pharmacist is distinct from the role of the pharmacist in a community setting. However, they are synergistic. Pharmacists working in general practice will, in the main, work with patients who have long term conditions to support them with their medicines and self-management of their condition by helping with the development and review of individual care plans. These patients will not generally be those with minor illnesses which can be treated by seeing a pharmacist in a community setting and for whom community pharmacy will remain the first, and most appropriate, option.

The below Parliamentary question was asked by Royston Smith on 2016-03-23.

To ask the Secretary of State for Health, if he will take steps to ensure that community pharmacies are not adversely affected by the localising of clinical pharmacists in GP surgeries.

Alistair Burt

Community pharmacy is a vital part of the National Health Service and can play an even greater role. In the Spending Review, the Government re-affirmed the need for the NHS to deliver £22 billion in efficiency savings by 2020/21 as set out in the NHS’s own plan, the Five Year Forward View. Community pharmacy is a core part of NHS primary care and has an important contribution to make as the NHS rises to these challenges. The Government believes efficiencies can be made without compromising the quality of services or public access to them. Our aim is to ensure that those community pharmacies upon which people depend continue to thrive and so we are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared to others, considering factors such as location and the health needs of the local population.

The Government’s vision is for a more efficient, modern system that will free up pharmacists to spend more time delivering clinical and public health services to the benefit of patients and the public.

We have been in detailed discussions with the Pharmaceutical Services Negotiating Committee (PSNC) since December 2015 regarding the Government’s proposals for community pharmacy in 2016/17 and beyond, including the proposal for a Pharmacy Access Scheme. In parallel, we also want to hear views on our proposals from across the sector and from patient groups. We published our open letter to the PSNC on 17 December 2015 and on 27 January 2016 we published a set of slides setting out the proposals with a foreword by the Chief Pharmaceutical Officer.

We announced on 16 March 2016 that the consultation period was to be extended to allow more time to develop the proposed changes with the PSNC and others. It will now close on 24 May 2016.

Once we have carefully considered the outcomes from the consultation, we are looking to communicate final decisions as soon as possible, so that pharmacy contractors are fully informed some months before the funding reduction starts from October 2016.

The role of the general practice pharmacist is distinct from the role of the pharmacist in a community setting. However, they are synergistic. Pharmacists working in general practice will, in the main, work with patients who have long term conditions to support them with their medicines and self-management of their condition by helping with the development and review of individual care plans. These patients will not generally be those with minor illnesses which can be treated by seeing a pharmacist in a community setting and for whom community pharmacy will remain the first, and most appropriate, option.